Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...

CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...

American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...

Markets have hardly recovered from the DeepSeek shock and have just met trade tariff headwinds. Nonetheless, these stocks are ...

Markets have hardly recovered from the DeepSeek shock and have just met trade tariff headwinds. Nonetheless, these stocks are ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other undervalued defensive Stocks for ...

The stock market’s positive momentum ... 150 percentage points (see more details here). GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a British global pharmaceutical and healthcare ...

CureVac is developing an mRNA bird flu shot in collaboration with London-based pharma giant GlaxoSmithKline (GLAXO.BO). Pfizer stock (PFE) ticked up a much more modest 0.9%, while GSK itself ...

GlaxoSmithKline (GSK) continues to be the subject of takeover ... a far cry from the middle of 2013 when the stock was trading at a little below 1,750 pence. Last year's corruption scandal in ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...